The serotonergic neurons of the dorsal raphe (DR) nucleus in the CNS are involved in fear, anxiety and depression. Depression and anxiety occur quite frequently in postmenopausal women, but estrogen replacement to correct these CNS disorders is at present not favored because estrogen carries with it an increased risk for breast cancer. Serotonin synthesis, release and reuptake in the DR are targets of pharmaceuticals in the treatment of depression. In the present study we have examined by immunohistochemistry, the expression of two nuclear receptors, that is, the estrogen receptors ERa and ERb. We found that ERb but not ERa is strongly expressed in the DR and there is no sex difference and no change with ageing in the number of tryptophan hydroxylase (TPH)-positive neurons in the DR of wild-type (WT) mice. However, in ovariectomized (OVX) WT and in ERb À/À mice, there was a marked reduction in the number of TPH-positive normal-looking neurons and a marked increase in TPH-positive spindle-shaped cells. These neuronal changes were prevented in mice 1--3 weeks (but not 10 weeks) after OVX by the selective ERb agonist, LY3201, given as continuous release pellets for 3 days. The ERb agonist had no effects on glucose homeostasis. Thus, the onset of action of the ERb agonist is rapid but there is a limited window in time after estrogen loss when the drug is useful. We conclude that, rather than estradiol, ERb agonists could be useful pharmaceuticals in maintaining functional DR neurons to treat postmenopausal depression.
INTRODUCTION
Estrogen receptor (ER) b is widely expressed in the developing mouse brain and is essential for the correct layering of the cortex. 1--3 With immunohistochemical techniques, ERb expression has been studied in several laboratories. 4 There is little or no ERb expression in adult pituitary 5, 6 or in the endometrium, 5 whereas in the mammary gland ERb is abundant and has antiproliferative, pro-differentiative effects. 7 In contrast to developing mouse brain where ERb is abundant, in adults, expression of ERb is confined to few areas of the brain. Owing to lack of ERb expression in the pituitary, selective ERb agonists do not interrupt the hypothalamo--pituitary--gonadal axis, nor do they cause growth of the mammary gland or uterus. 5, 8 It has been known for some time that ERa is not expressed in the serotonergic neurons of the dorsal raphe (DR) but that estrogen influences the serotonergic system. 9 For many years, the effects of estrogen on the DR were thought to be indirect. This view had to be revised after the discovery of ERb in 1996 and the finding in several laboratories of the expression of ERb in neurons of the DR. 10 ,11 E 2 is equally potent on ERa and ERb, but agonists selective for ERa or ERb have been synthesized. We have obtained one ERb-selective agonist from the pharmaceutical company Eli Lilly (LY3201) and shown that it is anxiolytic. 12 In the present study we have examined the expression of ERb in the DR of (wild-type) WT mice and the consequences to the DR neurons of loss of ERb. In addition, we have investigated the effects of LY3201 on tryptophan hydroxylase (TPH) in the DR and, as we have previously reported that one ERb-seletive ligand, 2,3-bis(4-hydroxyphenyl)-propionitrile (DPN), is diabetogenic, 13 we have examined the effects of LY3201 on glucose homeostasis.
MATERIALS AND METHODS Animals WT, ERb
À/À and ERa À/À mice were generated as previously described. 14--16 All mice were backcrossed to a C57BL6 background for at least 10 generations. Animals were housed on a 12-h light/dark cycle under controlled temperature (20--22 1C) and fed a standard pellet diet with water provided ad libitum. For brain collection, mice were deeply anesthetized with carbon dioxide and perfused manually using gravity through left ventricle with phosphate-buffered saline followed by 4% paraformaldehyde. Brains were dissected and postfixed in the same fixative overnight at 4 1C and were processed for 5-mm paraffin sections. To examine glucose homeostasis, skeletal muscle and white adipose tissue were excised, frozen immediately for real-time quantitative PCR and blood was collected from the orbital sinus for serum metabolic panel measurements.
Ovariectomy and treatment with E2 or LY3201
At the age of 6 months, 45 WT mice were ovariectomized (OVX) bilaterally through a single dorsal midline incision across the lumbar region, making both ovaries accessible. The ovary-attached fat pad was gently grasped to lift and exteriorize the ovary. Subsequently, the periovarian sac was peeled back over the surface of the ovary, allowing removal of the whole ovary. This surgery was performed at Jackson Laboratory (Sacramento, CA, USA).
1, 3 and 10 weeks after OVX, mice were randomly placed in three groups as follows: (1) five mice were inserted with placebo pellets; (2) 
Immunohistochemistry and cell count
Paraffin-embedded sections were de-waxed in xylene followed by rehydration in graded concentrations of ethanol. Antigen retrieval was achieved by placing slides in 97 1C citrate buffer (pH 6.0) for 10 min. Endogenous peroxidase was quenched by 30 min incubation in 1% H 2 O 2 in 50% methanol followed by blocking of unspecific protein binding with 3% bovine serum albumin for 10 min. Sections were incubated with rabbit anti-ERa (1:500, Santa Cruz Biotechnology, Santa Cruz, CA, USA), chicken anti-ERb (1:200 home made) or mouse anti-TPH (1:800, SigmaAldrich, St. Louis, MO, USA) in 3% bovine serum albumin with phosphatebuffered saline and 0.1% NP40 at room temperature overnight. Corresponding HRP polymer solution (Bio care medical, Concord, CA, USA) was added for 30 min at room temperature for ERa and TPH staining. Sections were incubated for 1 h with biotinylated secondary antibodies at a 1:200 dilution and incubated with avidin-biotinylated horseradish peroxidase complex (Vector laboratories, Burlingame, CA, USA) for 1 h for ERb staining. The slides were developed using DAB (Dako, Carpinteria, CA, USA) and counterstained with hematoxylin. To count the number of TPHpositive cells, six serial sections that included the DR were chosen from each mouse, and TPH cells were counted in the entire DR and lateral part of the DR by two independent investigators. The location of the DR and lateral part of the DR was determined as previously described. 17 The effects of LY3201 on glucose homeostasis
To observe the effects of LY3201 on glucose metabolism, WT male mice were administered LY3201 by oral gavage (0.35 mg kg À1 per day) for 3 days. There were 27 mice in the vehicle-treated and 27 in the LY3201- Figure 3 . At the age of 6 months, wild-type (WT) female mice were ovariectomized (OVX). At 1, 3, and 10 weeks (W) after OVX, mice were implanted subcutaneously with placebo, E 2 or LY3201 pellets. The duration of hormone exposure was 3 days. There were five mice in each group. Photomicrographs represent the change in tryptophan hydroxylase (TPH) positivity in the dorsal raphe (DR) and the chart represents the TPH-positive cell numbers in whole or lateral part of the DR. The number of TPH-positive cells was significantly lower in mice 3 and 10 weeks after OVX than in intact WT female mice (a, d, g). LY3201 treatment significantly restored TPH-positive cells in the groups 1 week and 3 weeks after OVX (c, f). Estradiol pellets did not fully restore TPH expression in mice 3 weeks after OVX (e) although it restored the expression of TPH in 1 week (b). LY3201 treatment 10 weeks after OVX did not restore TPH-positive cells and neither did E 2 treatment (h, i). Data are presented as means±s.e.m. *Po0.05 versus untreated females, Po0.05 versus placebo-treated mice in the group. Scale bar represents 100 mm.
Estrogen receptor b in the dorsal raphe H Suzuki et al treated group. The mice were then subdivided into three groups as follows: (1) nine mice treated with vehicle and nine with LY3201 were submitted to a glucose tolerance test; (2) nine mice treated with vehicle and nine with LY3201 were submitted to an insulin tolerance test; and (3) nine mice treated with vehicle and nine with LY3201 were used for blood and tissue collection.
Real-time reverse transcription PCR Total RNA was extracted from frozen skeletal muscle and white adipose tissue by using the RNeasy Mini KIT (Qiagen, Valencia, CA, USA) followed by cDNA synthesis using SuperScript III reverse transcriptase (Invitrogen, Grand Island, NY, USA). All genes were analyzed with the SYBR green detection method by using the Applied Biosystems 7500 real-time PCR machine (Foster City, CA, USA) and each PCR was plated in triplicate. 36B4 was used as internal control for each of the PCR amplifications. The following primer sequences were used: for insulin receptor substrate-1 (IRS-1), 5 0 -TCTACACCCGAGACGAACACT-3 0 and 5 0 -TGGGCCTTTGCCCGAT TATG-3 0 ; for phosphoinositide-3-kinase (PI3K)
RESULTS

Expression of ERs in the DR of adult male mice
At the age of 6 months, the mid brains of five WT male mice were immunostained with antibodies against ERa and ERb. Several ERapositive neurons were found in the periaqueductal gray but none was detected in the DR. ERb-positive neurons were abundant in the DR (Figure 1 ). All staining was nuclear. These data imply that ERb, but not ERa, may directly influence the DR, which is the primary center of serotonin projections, with known functions in modulating the limbic system and thus mood disorders.
Effects of gender and age on expression of TPH in the DR To observe the effect of age and gender on serotonergic neurons, we examined expression of TPH, which is the rate-limiting enzyme in the synthesis of serotonin (5-HT) in the brain. Brains of 3-and 15-month-old WT mice were immunostained with a monoclonal antibody raised against TPH; n ¼ 5). As expected, TPH was abundantly expressed in neurons of the DR. There was no sex difference and no change with aging in the number of TPH-positive neurons (Figure 2) . We counted the number of TPHpositive cells in the whole DR and lateral part of the DR separately because it has been reported previously that the lateral but not the ventromedial DR is the stress-sensitive DR subregion. 18 Effect of inactivation of ERb on TPH in the DR There was a marked decrease in the expression of TPH in ERb À/À mice ( Figure 2 ). In addition, many TPH-positive neurons in the lateral part of the DR were spindle shaped. No spindle-shaped cells were detected in the DR of aged WT mice. The data suggests that change in the morphology of the neurons of the lateral part of the DR resulted from the loss of ERb.
The effects of OVX and treatment with E 2 or ERb-selective agonist on the expression of TPH in the DR Although it is known that E 2 affects serotonergic activities, the site of E2 action has been unclear because there is no expression of ERa in the DR. We examined the impact of estrogen ablation on the serotonergic neurons and effects of E 2 or ERb-selective agonist (LY3201) supplementation on this system. At the age of 6 months, WT female mice were ovariectomized (OVX). At 1, 3 and 10 weeks , d, g ). In the E 2 -treated group there was a small restoration of ERb-positive cells (b, e). LY3201 treatment strongly restored ERb expression in the groups in which treatment started 1 and 3 weeks (c, f ) after OVX but had no effect in the group in which replacement started 10 weeks after OVX (i). Scale bars are 100 mm in lower magnification and 20 mm in higher magnification.
after the OVX, these mice were implanted with placebo, E 2 or LY3201 pellets subcutaneously (n ¼ 5). Three days after implantation the mid brain was examined by immunohistochemistry. Compared with intact 6-month-old WT female mice, there was a significant decrease in the number of TPH-positive neurons in the lateral part of the DR 3 and 10 weeks after the OVX (Figure 3 ). In the LY3201 and E 2 treatment groups, when treatment was started 1 and 3 weeks after OVX, the number of TPH-positive neurons was higher than in the placebo-treated OVX mice. However, 10 weeks after estrogen deprivation, a 3-day treatment with LY3201 could no longer restore TPH-positive neurons (Figure 3 ). These changes were also apparent especially in lateral part of the DR.
The effects of OVX and treatment with E 2 or ERb-selective agonist on the expression of ERb in the DR We analyzed the change of ERb-expression in the DR. One week after the OVX, ERb-positive neurons were still abundant in the DR.
Both E 2 and LY3201 supplementation increased the ERb expression in the DR but a more intense effect was observed in LY3201-treated mice ( Figure 4 ). The expression of ERb gradually decreased in the mice treated with placebo pellets 3 weeks after the OVX, but ERb immunoreactivity was maintained by E 2 or LY3201 treatment. Ten weeks after OVX there was a marked reduction in the number of ERb-positive neurons, and E 2 and LY3201 treatment resulted in only small increases in ERb staining (Figure 4 ).
Glucose and insulin tolerance tests of the mice treated with ERb-selective agonist As we have previously reported that another ERb agonist, DPN, is diabetogenic, we examined glucose homeostasis in the mice treated with LY3201. Before testing, the mice were fasted for 12 h and then received 1.0 U kg À1 of normal insulin (Humulin R, Eli Lilly) or 1 g kg À1 body weight of a 100 mg ml À1 glucose solution in sterile water delivered by intraperitoneal injection. No significant differences were observed in the glucose tolerance test: Thirty minutes after a bolus of glucose was given intraperitoneally to vehicle-and LY3201-treated mice, the glucose peak levels and the area under the plasma concentration/time curve (areas under the curve, AUC) in LY3201-treated mice was slightly lower than in the vehicle-treated mice (Figures 5a and c) .
After overnight fast, LY3201-treated mice had a small but significantly higher glucose level than did vehicle-treated mice (110 vs 90 mg dl À1 glucose). Five and 120 min after a bolus insulin was given intraperitoneally to vehicle-and LY3201-treated mice, the glucose peak levels in LY3201-treated mice were higher than in the vehicle-treated mice, and there was a small increase of AUC (Figures 5b and d) .
Insulin signaling cascade in skeletal muscle and white adipose tissue Compared with vehicle-treated mice, treatment with LY3201 for 3 days caused a small reduction of GLUT4 expression and had no effects on IRS-1 or PI3K mRNA levels in skeletal muscle. However, in white adipose tissue, LY3201 treatment caused a twofold increase in the levels of GLUT4, IRS-1 and PI3K mRNA (Figure 5e ).
DISCUSSION
It has been pointed out before that estrogen might affect the serotonin system and consequently alter mental status. 19 Previous studies have demonstrated that ERb mRNA was found in the DR. 11, 20 The expression of ERb mRNA in the DR is reduced after OVX and replacement with E 2 can restore the gene expression profile toward normal. 21 Our immunohistochemical study shows the presence of ERb in the DR, which is the primary brain center of serotonin projections. The expression of ERb, not ERa, in the DR is enough to envisage a role for this receptor in the serotonergic systems and in modulation of the limbic system and mood disorders.
The number of TPH-positive cells in the DR did not change with age or gender in WT mice. However, as ERb À/À aged, there was a marked reduction in the number of TPH-positive normal-looking neurons and an increase in TPH-positive spindle-shaped cells in the lateral DR. It has been reported previously that the lateral part of the DR is the stress-sensitive subregion of the DR 18 and is also sensitive to E 2 . 19 In addition, ERb but not ERa is expressed in the DR of adult mice. In view of this, it is possible to infer that loss of ERb function will lead to adult-onset changes in mood and the lateral part of the DR may have an important role in these changes.
One of the problems of treating depression with selective serotonin reuptake inhibitors (SSRIs) is a delay in the onset of action of these drugs that can be as long as 6 weeks. 22 The mode of action of the SSRIs is elevated synaptic concentrations of serotonin (5-HT). Early in the treatment with SSRIs, the elevated concentration of 5-HT results in a feedback decrease in release of serotonin. Later on, as SSRI treatment continues, the serotonergic system readjusts and the synaptic concentration of serotonin becomes elevated. The early negative feedback is mediated via terminal 5-HT 1B and somato-dendritic 5-HT 1A receptors and is thought to be responsible for the slow onset of the therapeutic effect of SSRIs. In the present study we have found that LY3201 treatment has a rapid onset effect on serotonergic activity with increased expression of TPH and ERb by 3 days of treatment of LY3201. Thus, LY3201 may be of clinical use in shortening the time of onset of the beneficial effects of SSRI. However, LY3201 only restored TPH expression in the DR when the duration of estrogen deprivation was o10 weeks. Previous research has shown that in women there is a window of opportunity after loss of ovarian function, during which hormone replacement therapy is effective in postmenopausal women. 23 It has also been shown that behavior of mice after OVX was restored by the treatment with E 2 or DPN, 24, 25 but the changes in behavior and the efficacy of E 2 replacement as a function of the time after OVX have not been studied. Such studies are required for understanding the mechanism of postmenopausal mood disorder and the involvement of ERb.
We have previously reported that the use of DPN for 3 days reduced GLUT4 expression in skeletal muscle 13 and that the block of ERb by tamoxifen in ERa À/À mice increased GLUT4 protein expression and improved glucose homeostasis. 26 These results raised the possibility that ERb activity could have diabetogenic effects. We have also reported that in ERb À/À mice there is a delay in the first phase of insulin release after an intraperitoneal bolus of glucose. 26 In the present study, we observed very mild alterations in glucose homeostasis with LY3201 treatment for 3 days. Instead, the glucose tolerance test revealed a discrete improvement in glucose tolerance, with decreased AUC. Although the insulin tolerance test indicated some decrease in insulin sensitivity, upon treatment with LY3201, the changes were within normal range.
In skeletal muscle, no changes were observed in IRS-1 or PI3K but there was a small decrease in GLUT4 expression. However, in adipose tissue, we detected a significant increase in GLUT4, IRS-1 and PI3K mRNA. Skeletal muscle is responsible for at least 75% of insulin-induced glucose uptake, 27 and recent studies in diabetic patients demonstrate that a reduction of GLUT4 expression in skeletal muscle by as little as 9% correlates with type 2 diabetes. 28--30 In our study, however, the reduction in GLUT4 gene expression was not enough to induce insulin resistance.
We conclude that 3-day treatment with LY3201 causes only mild alterations in glucose homeostasis but effectively restored TPH expression in the DR. We envisage that, rather than estradiol, ERb agonists could be useful pharmaceuticals in maintaining functional neurons in the DR to treat postmenopausal depression.
